Is a picture worth a thousand (forgotten) words?: Neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
The diminution in cognitive function reported to occur in patients treated with adjuvant cancer chemotherapy (a phenomenon known as 'chemo-fog, 'chemo-brain' or similar designation) is supported with varying degrees of evidence by prospective and retrospective clinical studies. However, the cognitiv...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 35; no. 1; pp. 1 - 10 |
|---|---|
| Autor principal: | |
| Formato: | diagnostic images Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105281551&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105281551 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 02694727 EV4 jtl: Journal of Clinical Pharmacy & Therapeutics issn: 02694727 maglogo: Y pubinfo: dt: Feb2010 vid: 35 iid: 1 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 105281551 105281551 2010523722 10.1111/j.1365-2710.2009.01044.x NLM20175809 105281551 ppf: 1 ppct: 9 formats: fmt: @attributes: type: P tig: atl: Is a picture worth a thousand (forgotten) words?: Neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'. aug: au: Raffa RB affil: Temple University School of Pharmacy, 3307 N. Broad Street, PA 19140; robert.raffa@temple.edu sug: subj: Chemotherapy, Cancer Adverse Effects Cognition Disorders Chemically Induced Cognition Disorders Diagnosis Neuroradiography Breast Neoplasms Drug Therapy Chemotherapy, Adjuvant Magnetic Resonance Imaging ab: The diminution in cognitive function reported to occur in patients treated with adjuvant cancer chemotherapy (a phenomenon known as 'chemo-fog, 'chemo-brain' or similar designation) is supported with varying degrees of evidence by prospective and retrospective clinical studies. However, the cognitive deficits are often subtle and the methodologies used to measure them not consistent. Additionally, patients might be able to compensate for the deficits, thereby leading to underestimates of the problem by this type of assessment. For these reasons, direct neuroimaging techniques might provide additional insight. The relatively few such studies, and fewer electrophysiological studies, offer an alternative way to evaluate changes that might be related to cognitive deficits in patients treated with cancer chemotherapeutic regimens. pubtype: Academic Journal doctype: diagnostic images Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|